UNK_SMART TOUCH BIDIRECTIONAL SF
Report
- Report Number
- 2029046-2020-00619
- Event Type
- Injury
- Date Received
- May 26, 2020
- Date of Event
- December 31, 2018
- Report Date
- May 4, 2020
- Manufacturer
- BIOSENSE WEBSTER INC
- Product Code
- LPB
- PMA / PMN Number
- UNK
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
PRODUCT COMPLAINT # (B)(4). SINCE THE PRODUCT WAS NOT RETURNED FOR ANALYSIS, NO PRODUCT FAILURE ANALYSIS CAN BE CONDUCTED AND NO DETERMINATION OF POSSIBLE CONTRIBUTING FACTORS COULD BE MADE. DEVICE HISTORY RECORD (DHR) REVIEW CANNOT BE CONDUCTED BECAUSE THE NO LOT NUMBER WAS PROVIDED BY THE CUSTOMER. INFORMATION REGARDING PATIENT WEIGHT, HEIGHT, MEDICAL HISTORY, RACE, AND ETHNICITY WAS NOT REPORTED.
THIS COMPLAINT IS FROM A LITERATURE SOURCE. AS REPORTED IN THE LITERATURE PUBLICATION ENTITLED, ¿HIGH-POWER APPLICATION IS ASSOCIATED WITH SHORTER PROCEDURE TIME AND HIGHER RATE OF FIRST-PASS PULMONARY VEIN ISOLATION IN ABLATION INDEX-GUIDED ATRIAL FIBRILLATION ABLATION¿ 1 PATIENT WITH ATRIAL FIBRILLATION, FROM LP-GROUP, WHO UNDERWENT CIRCUMFERENTIAL PULMONARY VEIN ISOLATION EXPERIENCED ARTERIOVENOUS FISTULA IN THE FEMORAL VEIN PUNCTURE SITE. OBJECTIVES: ABLATION INDEX PF THE CIRCUMFERENTIAL PULMONARY VEIN ISOLATION (CPVI) AND THE ROLE OF RADIOFREQUENCY POWER IN AI-GUIDED CPVI WERE REVIEWED. METHODS: 60 PATIENTS WITH AF UNDERGOING THE FIRST CPVI FROM JULY 2018 TO DECEMBER 2018 WERE INVESTIGATED. NO PATIENTS WITH LONG-STANDING AF WERE INCLUDED IN THIS STUDY. IN THE FIRST PART OF THE STUDY, WE RANDOMLY ASSIGNED THE 40 PATIENTS TO LP (N = 20) AND MEDIUM-POWER (MP; N = 20) APPLICATION GROUPS (FIGURE 1). IN THE NEXT PART, THE FOLLOWING 20 PATIENTS TO THE HP APPLICATION GROUP WERE ASSIGNED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 552261 | UNK_SMART TOUCH BIDIRECTIONAL SF | CARDIAC ABLATION PERCUTANEOUS CATHETER | LPB | BIOSENSE WEBSTER INC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR | Other |